MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib
Abstract Background Triple negative breast cancer (TNBC) is a particularly aggressive and difficult-to-treat subtype of breast cancer that requires the development of novel therapeutic strategies. To pave the way for such developments it is essential to characterize new molecular players in TNBC. Mi...
Main Authors: | Katharina Jonas, Felix Prinz, Manuela Ferracin, Katarina Krajina, Barbara Pasculli, Alexander Deutsch, Tobias Madl, Beate Rinner, Ondrej Slaby, Christiane Klec, Martin Pichler |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Breast Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13058-023-01716-2 |
Similar Items
-
Lipid kinases PIP5Ks and PIP4Ks: potential drug targets for breast cancer
by: Yue Jin, et al.
Published: (2023-12-01) -
MiR-4646-5p Acts as a Tumor-Suppressive Factor in Triple Negative Breast Cancer and Targets the Cholesterol Transport Protein GRAMD1B
by: Katharina Jonas, et al.
Published: (2023-12-01) -
Membrane-mediated dimerization potentiates PIP5K lipid kinase activity
by: Scott D Hansen, et al.
Published: (2022-08-01) -
Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib
by: Liwei Lang, et al.
Published: (2020-02-01) -
“The emerging role of capivasertib in breast cancer”
by: Angeliki Andrikopoulou, et al.
Published: (2022-06-01)